Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ · Healthcare
Syndax Pharmaceuticals Inc. Gross Profit 2020–2025
Syndax Pharmaceuticals Inc. annual/quarterly gross profit history and growth rate from 2024 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Syndax Pharmaceuticals Inc. gross profit for the quarter ending March 31, 2026 was 62.2 M, a 224.85% increase year-over-year.
- Syndax Pharmaceuticals Inc. gross profit for the twelve months ending March 31, 2026 was 208.7 M.
- Syndax Pharmaceuticals Inc. annual gross profit for 2025 was 165.4 M, a 623.65% increase from 2024.
- Syndax Pharmaceuticals Inc. annual gross profit for 2024 was 22.9 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Syndax Pharmaceuticals Inc. Gross Profit — FAQ
Syndax Pharmaceuticals Inc. (SNDX) gross profit over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Syndax Pharmaceuticals Inc.'s gross profit?
Syndax Pharmaceuticals Inc. (SNDX) reported gross profit of $165M for fiscal 2025.
Where can I see SNDX's gross profit history?
The chart and table above show Syndax Pharmaceuticals Inc.'s gross profit by year and by quarter, including the growth rate.